EPC1 may participate in the genomics, transcriptomics, proteomics, and immunomics of HNSCC, and the results can provide a reference for the development of targeted drugs and evaluation of patient prognosis. This evidence concerns the gene EPC1 and head and neck squamous cell carcinoma.